Skip to main content
SpringerLink
Log in

Parathyroid Gland

  • Chapter
  • First Online:
The Pathophysiologic Basis of Nuclear Medicine

Abstract

The last organ to be recognized in man, the parathyroid glands, was discovered in 1880 by Ivar Sandstrom, a Swedish medical student. The discovery attracted little attention initially. Later, with the uncovering of the relationship of the glands to significant bone disease, interest quickened. In the early 1900s, Jacob Erdheim demonstrated that the four parathyroid glands were enlarged in osteomalacia and in rickets and thought it was a compensatory phenomenon. Subsequently, occasional cases of bone disease were encountered in which only a single gland was enlarged. In 1915, Friedrich Schlaugenhaufer suggested that enlargement of a single parathyroid gland might be the cause of the bone disease, not its result. The first parathyroidectomy for von Recklinghausen’s disease of the bone was performed by Felix Mandl in 1925 in Vienna. Subsequently, the parathyroid glands were shown to be affected by a number of primary pathological processes – neoplasia (adenoma and carcinoma) and hyperplasia (wasserhelle cell and chief cell types) – that resulted in overactivity and required surgical removal of one or more of them [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carney JA (1996) The glandulae parathyroideae of Ivar Sandstrom. Contributions from two continents. Am J Surg Pathol 20:1123–1144

    Article  CAS  PubMed  Google Scholar 

  2. Maxon HR, Elgazzar AH (1988) Parathyroid imaging. In: Gelfand G, Thomas S (eds) Effective use of computers in nuclear medicine. McGraw Hill, New York, pp 485–496

    Google Scholar 

  3. Akerstrom G, Grimelius L, Johansson H, Lundquist H, Pertoft H, Bergstrom R (1981) The parenchymal cell mass in normal human parathyroid glands. Acta Pathol Microbiol Immunol Scand 89(A):367

    Google Scholar 

  4. Grimelius L, Ackerstrom G, Bonderson L, Juhlin C, Johnsson H, Ljunghall S, Rastad J (1991) The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism. World J Surg 15:698–705

    Article  CAS  PubMed  Google Scholar 

  5. Akerstrom G, Rastad J, Ljunghall S, Johnsson H (1990) Clinical and experimental advances in sporadic primary hyperparathyroidism. Acta Chir Scand 156:23–28

    CAS  PubMed  Google Scholar 

  6. Birkenhager JC, Bouillon R (1996) Asymptomatic hyperparathyroidism. Postgrad Med J 72:323–326

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Mitchell BK, Merrell RC, Kinder BK (1995) Localization studies in patients with hyperparathyroidism. Endocrinol Surg 75:483–498

    CAS  Google Scholar 

  8. Smith JR, Oates ME (2004) Radionuclide imaging of the parathyroid glands: patterns, pearls, and pitfalls. Radiographics 24:1101–1115

    Article  PubMed  Google Scholar 

  9. Berland T, Smith SL, Huguet KL (2005) Occult fifth gland intrathyroid parathyroid adenoma identified by gamma probe. Am Surg 71:264–266

    PubMed  Google Scholar 

  10. Kunstman JW, Kirsch JD, Mahajan A, Udelsman R (2013) Clinical review: parathyroid localization and implications for clinical management. J Clin Endocrinol Metab 98:902–912

    Article  CAS  PubMed  Google Scholar 

  11. Akerstrom G, Malmaeus J, Bergstrom R (1984) Surgical anatomy of human parathyroid glands. Surgery 95:15–21

    Google Scholar 

  12. Ritter CS, Haughey BH, Miller B, Brown A (2012) Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 97:E1499–E1505

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Palestro C, Tomas M, Tronco G (2005) Radionuclide imaging of the parathyroid glands. Semin Nucl Med 35:266–276

    Article  PubMed  Google Scholar 

  14. Akerstrom G, Rudberg C, Grimelius L et al (1986) Histologic parathyroid abnormalities in an autopsy series. Hum Pathol 17:520–527

    Article  CAS  PubMed  Google Scholar 

  15. Heath H III (1991) Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 6:S63–S70

    Article  PubMed  Google Scholar 

  16. Fitzpatrick LA (1989) Hypercalcemia in the multiple endocrine neoplasia syndromes. Endocrinol Metab Clin North Am 18:741–752

    CAS  PubMed  Google Scholar 

  17. Skogseid B, Rastad J, Oberg K (1994) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 23:1–17

    CAS  PubMed  Google Scholar 

  18. Herfarth KK, Wells SA (1997) Parathyroid glands and the multiple endocrine neoplasia syndromes and familial hypocalciuric hypercalcemia. Semin Surg Oncol 13:114–124

    Article  CAS  PubMed  Google Scholar 

  19. Mallette LE (1994) Management of hyperparathyroidism in multiple endocrine neoplasia syndromes and other familial endocrinopathies. Endocrinol Metab Clin North Am 23:19–36

    CAS  PubMed  Google Scholar 

  20. Duh QY, Hybarger CP, Geist R, Gamsu G, Goodman PC, Gooding GA, Clark OH (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154:142–148

    Article  CAS  PubMed  Google Scholar 

  21. Beus KS, Stack BC Jr (2004) Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am J Otolaryngol 25:308–312

    Article  PubMed  Google Scholar 

  22. Nishiyama RH, Farhi D, Thompson NW (1979) Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules. Surg Clin North Am 59:65–75

    CAS  PubMed  Google Scholar 

  23. Ogburn P, Black B (1956) Primary hyperparathyroidism and papillary adenocarcinoma of the thyroid: report of four cases. Mayo Clin Proc 31:295–298

    CAS  Google Scholar 

  24. Prinz RA, Barbato AL, Braithwaite SS (1982) Simultaneous primary hyperparathyroidism and nodular thyroid disease. Surgery 92:454–458

    CAS  PubMed  Google Scholar 

  25. Hedman IL, Tisell LE (1984) Associated hyperparathyroidism and non-medullary thyroid carcinoma: the etiological role of radiation. Surgery 95:392–397

    CAS  PubMed  Google Scholar 

  26. Attie JN, Vardhan R (1993) Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases. Head Neck 15:20–23

    Article  CAS  PubMed  Google Scholar 

  27. Burmeister LA, Sandberg M, Carty SE (1997) Thyroid carcinoma found at parathyroidectomy: Association with primary, secondary and tertiary hyperparathyroidism. Cancer 79:1611–1616

    Article  CAS  PubMed  Google Scholar 

  28. Sidhu S, Campbell P (2000) Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg 70:285–287

    Article  CAS  PubMed  Google Scholar 

  29. Bentrem DJ, Angelos P, Talamonti MS (2002) Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid 12:1109–1112

    Article  PubMed  Google Scholar 

  30. Arem R, Lim-Abrahan MA, Mallette LE (1986) Concomitant Graves’ disease and primary hyperparathyroidism. Influence of hyperthyroidism on serum calcium and parathyroid hormone. Am J Med 80:693–698

    Article  CAS  PubMed  Google Scholar 

  31. Sy WM, Mittal AK (1975) Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol 48:878–884

    Article  CAS  PubMed  Google Scholar 

  32. Thompson NW, Eckhauser FE, Harness JK (1982) The anatomy of primary hyperparathyroidism. Surgery 92:814–821

    CAS  PubMed  Google Scholar 

  33. Wang CA (1976) The anatomic basis of parathyroid surgery. Ann Surg 183:271–275

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Simeone DM, Sandelin K, Thompson NW (1995) Undescended superior parathyroid gland: a potential cause of failed cervical exploration for hyperparathyroidism. Surgery 118:949–956

    Article  CAS  PubMed  Google Scholar 

  35. Shen W, Duren M, Morita E, Higgins C, Duh QY, Siperstein AE, Clark OH (1996) Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 131:861–869

    Article  CAS  PubMed  Google Scholar 

  36. Doppman JL, Skarulis MC, Chen CC et al (1996) Parathyroid adenomas in the aortopulmonary window. Radiology 201:456–462

    Article  CAS  PubMed  Google Scholar 

  37. Tezelman S, Shen W, Shaver JK et al (1993) Double parathyroid adenomas: clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 218:300–309

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Bartsch D, Nies C, Hasse C et al (1995) Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism. Br J Surg 82:926–929

    Article  CAS  PubMed  Google Scholar 

  39. Nguyen BD (1999) Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy. Radiographics 19:601–614

    Article  CAS  PubMed  Google Scholar 

  40. Clark OH, Duh QY (1989) Primary hyperparathyroidism: a surgical perspective. Endocrinol Metab Clin North Am 18:701–714

    CAS  PubMed  Google Scholar 

  41. McHenry CR, Lee K, Saadey J et al (1996) Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg 183:25–30

    CAS  PubMed  Google Scholar 

  42. Bergenfelz A, Tennvall J, Valdermarsson S et al (1997) Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 121:601–605

    Article  CAS  PubMed  Google Scholar 

  43. Rogers LA, Fetter BF, Peete WPJ (1969) Parathyroid cyst and cystic degeneration of parathyroid adenoma. Arch Pathol 88:476–479

    CAS  PubMed  Google Scholar 

  44. Fallon MD, Haines JW, Teitelbaum SL (1982) Cystic parathyroid gland hyperplasia-hyperparathyroidism presenting as a neck mass. Am J Clin Pathol 77:104–107

    CAS  PubMed  Google Scholar 

  45. Turner WJD, Baergen RN, Pellitteri PK, Orloff LA (1996) Parathyroid lipoadenoma: case report and review of the literature. Otolaryngol Head Neck Surg 114:313–316

    Article  CAS  PubMed  Google Scholar 

  46. Fleischer J, Becker C, Hamele-Bena D et al (2004) Oxyphil parathyroid adenoma: a malignant presentation of a benign disease. J Clin Endocrinol Metab 89:5948–5951

    Article  CAS  PubMed  Google Scholar 

  47. Cummings CW (2005) Otolaryngology: head and neck surgery, 4th edn. Mosby, Philadelphia

    Google Scholar 

  48. Cheng L, Bostwick DG (2011) Endocrine pathology. In: Essentials of Anatomic Pathology, 3rd edn. Springer, Berlin, pp 927–928

    Chapter  Google Scholar 

  49. Rinsho N (1995) Primary hyperparathyroidism, pathologic findings and ultrastructure. Jpn J Clin Med 53:861–863

    Google Scholar 

  50. Baglin A, Junien C, Prinseau J (1991) Mechanism of parathyroid cell proliferation in primary hyperparathyroidism. Presse Med 20:803–808

    CAS  PubMed  Google Scholar 

  51. Cook M, Qureshi Y, Todd C, Cummins R (2012) An unusual ectopic location of a parathyroid carcinoma arising within the thyroid gland. J Clin Endocrinol Metab 97:1829–1833

    Article  CAS  PubMed  Google Scholar 

  52. Lack CA, Rarber JL, Rubin E (1999) The endocrine system. In: Rubin E, Farber JL (eds) Pathology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1179–1183

    Google Scholar 

  53. Kilgore EJ, Teigen EL, Cowan RJ (1996) Imaging of transplanted parathyroid tissue in a patient with recurrent hyperparathyroidism. Clin Nucl Med 21:383–386

    Article  CAS  PubMed  Google Scholar 

  54. Chen CC, Premkumar A, Hill SC, Skarulis MC, Spiegel AM (1995) Tc-99m sestamibi imaging of a hyperfunctioning parathyroid autograft with Doppler ultrasound and MRI correlation. Clin Nucl Med 20:222–225

    Article  CAS  PubMed  Google Scholar 

  55. Lee VS, Spritzer CE, Coleman RE, Wilkinson RH Jr, Coogan AC, Leight GS Jr (1995) Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging. Radiology 197:627–633

    Article  CAS  PubMed  Google Scholar 

  56. Walker RP, Paloyan E, Gopalsami C (2004) Symptoms in patients with primary hyperparathyroidism: muscle weakness or sleepiness. Endocr Pract 10:404–408

    Article  PubMed  Google Scholar 

  57. Wang CA (1977) Parathyroid re-exploration: a clinical and pathological study of 112 cases. Ann Surg 186:140

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Assalia A, Inabnet WB (2004) Endoscopic parathyroidectomy. Otolaryngol Clin North Am 37:871–886

    Article  PubMed  Google Scholar 

  59. Thomas SK, Wishart GC (2003) Trends in surgical techniques. Nucl Med Commun 24:115–119

    Article  CAS  PubMed  Google Scholar 

  60. O’Doherty MJ, Kettle AG (2003) Parathyroid imaging: preoperative localisation. Nucl Med Commun 24:125–131

    Article  PubMed  Google Scholar 

  61. Erdman WA, Breslau NA, Weinreb JC, Weatherall P, Setiawan H, Harrell R, Snyder W (1989) Noninvasive localization of parathyroid adenomas: a comparison of X-ray computerized tomography, ultrasound, scintigraphy and MRI. Magn Reson Imaging 7:187–194

    Article  CAS  PubMed  Google Scholar 

  62. Auffermann W, Gooding GA, Okerlund MD, Clark OH, Thurnher S, Levin KE, Higgins CB (1988) Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. Am J Roentgenol 150:1027–1033

    Article  CAS  Google Scholar 

  63. Peck WW, Higgins CR, Fisher MR, Ling M, Okerland MD, Clark OH (1987) Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology 163:415–420

    Article  CAS  PubMed  Google Scholar 

  64. Levin KE, Gooding GA, Okerlund M, Higgins CB, Norman D, Newton TH, Duh QY, Arnaud CD, Siperstein AE, Zeng QH et al (1987) Localizing studies in patients with persistent or recurrent hyperparathyroidism. Surgery 102:917–925

    CAS  PubMed  Google Scholar 

  65. Miller DL, Doppman JR, Shawker TH, Krudy AG, Norton JA, Vucich JJ et al (1987) Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology 162:133–137

    Article  CAS  PubMed  Google Scholar 

  66. Kettle A, O’Doherty M (2006) Parathyroid imaging: how good is it and how should it be done? Semin Nucl Med 36:206–211

    Article  PubMed  Google Scholar 

  67. Taillefer R, Boucher Y, Potviuc C et al (1992) Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with Tc-99m sestamibi (double phase study). J Nucl Med 33:1801–1807

    CAS  PubMed  Google Scholar 

  68. Dontu VS, Kettle AG, O’Doherty MJ, Coakley AJ (2004) Optimization of parathyroid imaging by simultaneous dual energy planar and single photon emission tomography. Nucl Med Commun 25:1089–1093

    Article  PubMed  Google Scholar 

  69. Vaz A, Griffiths M (2011) Parathyroid imaging and localization using SPECT/CT: initial results. J Nucl Med Technol 39:195–200

    Article  PubMed  Google Scholar 

  70. Takahashi H et al (2013) Fusion images of MIBI SPECT and MDCT improve diagnostic performance of localization study in hyperparathyroidism with multigland disease. J Nucl Med 54:44p

    Google Scholar 

  71. Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB et al (1996) PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770

    CAS  PubMed  Google Scholar 

  72. Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I (1998) [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism. Eur J Endocrinol 139:195–197

    Article  CAS  PubMed  Google Scholar 

  73. Beggs AD, Hain SF (2005) Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 26:133–136

    Article  PubMed  Google Scholar 

  74. Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G et al (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128

    Article  PubMed  Google Scholar 

  75. Quak E, Lheureux S, Renzik Y et al (2013) F18-Choline, a novel tracer for parathyroid adenoma? J Clin Endocrinol Metab 98(8):3111–3112

    Article  CAS  PubMed  Google Scholar 

  76. O’Doherty MJ, Kettle AG, Wells P, Collins RE, Coakley AJ (1992) Parathyroid imaging with technetium 99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 33:313–318

    PubMed  Google Scholar 

  77. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM (1993) Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53:977–984

    CAS  PubMed  Google Scholar 

  78. Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ et al (1996) Comparison of FDG-PET and sestamibi SPECT in primary hyperparathyroidism. J Nucl Med 37:1809–1815

    CAS  PubMed  Google Scholar 

  79. Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperthyroidism. Surgery 131:149–157

    Article  PubMed  Google Scholar 

  80. Bonjer HJ, Bruining HA, Valkema R, Lameris JS, de Herder WW, van der Harst E, Pols HA (1997) Single radionuclide scintigraphy with 99m-technetium-sestamibi and ultrasonography in hyperparathyroidism. Eur J Surg 163:27–32

    CAS  PubMed  Google Scholar 

  81. De Feo ML, Colagrande S, Biagini C, Tonarelli A, Bisi G, Vaggelli L, Borrelli D, Cicchi P, Tonelli F, Amorosi A, Serio M, Brandi ML (2000) Parathyroid glands: combination of 99mTc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules. Radiology 214:393–402

    Article  PubMed  Google Scholar 

  82. Slater A, Gleeson FV (2005) Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med 30:1–3

    Article  PubMed  Google Scholar 

  83. Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N (1998) Localization of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging. Nephron 78:48–53

    Article  CAS  PubMed  Google Scholar 

  84. Klieger P, O’Mara R (1998) The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging. Clin Nucl Med 23:208–211

    Article  CAS  PubMed  Google Scholar 

  85. Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci C, Miccoli P, Iacconi P, Bossio GB, Viacava P, Lazzeri E, Bartolozzi C (1996) Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol 166:1465–1470

    Article  CAS  PubMed  Google Scholar 

  86. Goris ML, Basso LV, Keeling C (1991) Parathyroid imaging. J Nucl Med 32:887–889

    CAS  PubMed  Google Scholar 

  87. Elgazzar AH, Maxon HR, Hertzberg V et al (1985) Parathyroid scintigraphy with and without thyroid hormone suppression. Proceedings of the Eastern Great Lakes Chapter, Society of Nuclear Medicine, Niagara Falls, New York

    Google Scholar 

  88. Takebayashi S, Hidai H, Chiba T, Takaga Y, Nagatani Y, Matsubara S (1999) Hyperfunctional parathyroid glands with Tc-99m MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40:1792–1797

    CAS  PubMed  Google Scholar 

  89. Bernard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G (1995) Rapid washout of technetium 99m MIBI from a large parathyroid adenoma. J Nucl Med 36:241–243

    Google Scholar 

  90. Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of Thallium-201/Tc-99m parathyroid subtraction scintigraphy. J Nucl Med 34:24–29

    CAS  PubMed  Google Scholar 

  91. Carpentier A, Jeannotte S, Verrault J, Lefebvre B, Bisson G, Mongeau CJ et al (1998) Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI and oxyphil cell count. J Nucl Med 39:1441–1444

    CAS  PubMed  Google Scholar 

  92. Pinero A, Rodriguez JM, Ortiz S, Soria T, Bermejo J, Claver MA et al (2000) Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg 122:851–855

    Article  CAS  PubMed  Google Scholar 

  93. Naddaf S, Anim JJ, Farghaly MM, Behbehani AE, Alshomar KA, Elgazzar AH (2005) Ultrastructure of hyperfunctioning parathyroid glands: does it explain various patterns of sestamibi uptake. JNM 45:78

    Google Scholar 

  94. Bleier B, LiVolsi V, Chalian A et al (2006) Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg 132:779–782

    Article  PubMed  Google Scholar 

  95. Kao A, Shiau YC, Tsai SC, Wang JJ, Ho ST (2002) Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging 29:1012–1015

    Article  CAS  PubMed  Google Scholar 

  96. Nichols K, Tomas M, Tronoco G, Palestro C (2011) Sestamibi parathyroid scintigraphy in multigland disease. Nucl Med Commun 33:43–50

    Article  Google Scholar 

  97. Caixas A, Berna L, Hernandez A, Tebar FJ, Madariaga P, Vegazo O, Bittini AL, Moreno B, Faure E, Abos D, Piera J, Rodriguez JM, Farrerons J, Puig-Domingo M (1997) Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery 121:535–541

    Article  CAS  PubMed  Google Scholar 

  98. Mudun A, Kocak M, Unal S, Cantez S (1995) Tc-99m MIBI accumulation in remnant thymus: a cause of false-positive interpretation in parathyroid imaging. Clin Nucl Med 20:379–380

    Article  CAS  PubMed  Google Scholar 

  99. Desai S, Yuille DL (1993) Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 34:1748–1750

    CAS  PubMed  Google Scholar 

  100. Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139:1175–1179

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Faculty of Medicine, Kuwait University Health Science Center, Kuwait City, Kuwait

    Abdelhamid H. Elgazzar MD, FCAP

  2. Department of Nuclear Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait

    Saud A. Alenezi MD, ABNM, FRCPC

Authors
  1. Abdelhamid H. Elgazzar MD, FCAP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saud A. Alenezi MD, ABNM, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdelhamid H. Elgazzar MD, FCAP .

Editor information

Editors and Affiliations

  1. Dept. Nuclear Medicine, Kuwait University Fac. Medicine, Safat, Kuwait

    Abdelhamid H. Elgazzar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Elgazzar, A.H., Alenezi, S.A. (2015). Parathyroid Gland. In: Elgazzar, A. (eds) The Pathophysiologic Basis of Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-06112-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-06112-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-06111-5

  • Online ISBN: 978-3-319-06112-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation